Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Bio Green Med Solution (UXI1) Stock Price & Analysis

1 Followers

UXI1 Stock Chart & Stats

€1.48€0.00(0.00%)
At close: 5:30 PM GMT+1
€2€4€6Oct 3Oct 20Oct 28Dec 3
Day’s Range
EUR 1.48 - EUR 1.48
52-Week Range
EUR 1.11 - EUR 1.55
Previous Close
EUR 1.48
Volume
N/A
Average Volume (3M)
0
Market Cap
EUR 5.30M
Enterprise Value
EUR 1.30M
Total Cash (Recent Filing)
EUR 3.79M
Total Debt (Recent Filing)
EUR 0
Price to Earnings (P/E)
―
Beta
-0.09
Next Earnings
Nov 18, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Growth

Revenue growth indicates improving commercialization traction and expanding business activity versus prior years. If maintained, the larger revenue base could provide operating leverage and support investment in the company’s evolving business model over the next several quarters.

Low Financial Leverage

An essentially debt-free balance sheet reduces creditor pressure and interest obligations, preserving financial flexibility while the company works toward profitability. Positive equity also provides a stronger capital base than a highly leveraged structure would during continued business development.

Strategic Business Transition

The shift toward fire safety products and equipment distribution represents a structural change in the company’s operating focus, rather than a short-term financial fluctuation. A clearer core business and cost-streamlining effort could improve execution and commercial focus over time.

Bears Say

Severe Operating Losses

The company has not yet demonstrated a scalable cost structure: operating losses exceed revenue and the net loss remains substantial. Continued losses can consume equity, limit internally funded growth, and make durable profitability dependent on a significant improvement in operating efficiency.

Persistent Cash Burn

Negative operating and free cash flow show that the business is still consuming cash to run and invest, rather than funding itself. Although operating cash burn improved from 2025, continued outflows keep funding needs elevated until the company approaches cash-flow breakeven.

Potential Shareholder Dilution

The proposed combination could materially reduce existing shareholders’ ownership and economic influence if it closes on the described terms. Such extreme dilution may offset operating improvements by transferring most future participation in the combined business to the transaction’s other stakeholders.

Bio Green Med Solution News

UXI1 FAQ

What was Bio Green Med Solution’s price range in the past 12 months?
Bio Green Med Solution lowest stock price was €1.11 and its highest was €1.55 in the past 12 months.
What is Bio Green Med Solution’s market cap?
Bio Green Med Solution’s market cap is €5.30M.
When is Bio Green Med Solution’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Bio Green Med Solution’s earnings last quarter?
Bio Green Med Solution released its earnings results on Aug 12, 2026. The company reported -€0.068 earnings per share for the quarter.
Is Bio Green Med Solution overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Bio Green Med Solution pay dividends?
Bio Green Med Solution does not currently pay dividends.
What is Bio Green Med Solution’s EPS estimate?
Bio Green Med Solution’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bio Green Med Solution have?
Bio Green Med Solution has 6,622,794 shares outstanding.
What happened to Bio Green Med Solution’s price movement after its last earnings report?
Bio Green Med Solution reported an EPS of -€0.068 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Bio Green Med Solution?
Currently, no hedge funds are holding shares in DE:UXI1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology